Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
/	O
Simvastatin	O
Attending:	O
___	O
Chief	O
Complaint:	O
AICD	O
Firing	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
female	O
nonischemic	O
cardiomyopathy	O
with	O
LVEF	O
of	O
20%,	O
hypertension,	O
mitral	O
valve	O
prolapse	O
with	O
severe	O
MR,	O
left	O
bundle-branch	O
block,	O
atrial	O
fibrillation	O
with	O
rapid	O
ventricular	O
rates,	O
and	O
VF	O
arrest	O
s/p	O
BiV	O
ICD	O
placement	O
___,	O
multiple	O
recent	O
admits	O
for	O
CHF	O
presenting	O
with	O
concern	O
for	O
AICD	O
firing	O
x2.	O
.	O
The	O
patient	O
reports	O
her	O
current	O
symptoms	O
began	O
on	O
___,	O
4	O
days	O
prior	O
to	O
presentation	O
when	O
she	O
began	O
experiencing	O
episodes	O
of	O
palpitations	O
lasting	O
up	O
to	O
4	O
hours.	O
The	O
palpitations	O
were	O
similar	O
to	O
prior	O
episodes	O
she	O
had	O
experienced	O
in	O
the	O
past	O
due	O
to	O
her	O
afib	O
and	O
she	O
was	O
unconcerned	O
at	O
that	O
time.	O
She	O
denies	O
experiencing	O
chest	O
pain,	O
lightheadedness,	O
nausea/vomiting,	O
but	O
does	O
report	O
a	O
headache	O
and	O
feeling	O
off-balance,	O
which	O
she	O
has	O
not	O
felt	O
with	O
prior	O
episodes	O
of	O
palpitations.	O
She	O
was	O
asymptomatic	O
the	O
day	O
prior	O
to	O
presentation.	O
The	O
night	O
of	O
presentation,	O
approximately	O
2	O
hours	O
prior	O
to	O
presentation	O
at	O
3am,	O
she	O
was	O
woken	O
from	O
sleep	O
due	O
to	O
her	O
AICD	O
firing.	O
She	O
reports	O
nausea	O
after	O
the	O
first	O
ICD	O
shock,	O
and	O
was	O
sitting	O
up	O
when	O
she	O
experienced	O
a	O
second	O
shock	O
10	O
minutes	O
later.	O
She	O
denies	O
prodromes	O
of	O
chest	O
pain,	O
lightheadedness,	O
dyspnea,	O
or	O
plapitations	O
prior	O
to	O
the	O
second	O
shock.	O
She	O
presented	O
to	O
the	O
ED	O
for	O
further	O
evaluation.	O
The	O
patient	O
denies	O
recent	O
vomiting,	O
chest	O
pain,	O
dyspnea,	O
lightheadedness,	O
recent	O
weight	O
gain,	O
pedal	O
edema.	O
She	O
denies	O
headache,	O
vision	B-Visual_impairment
changes,	B-Visual_impairment
numbness/tingling,	O
focal	O
weakness,	O
abdominal	O
pain.	O
.	O
Of	O
note,	O
the	O
patient	O
has	O
a	O
complicated	O
cardiac	O
history	O
which	O
started	O
with	O
longstanding	O
non-ischemic	O
cardiomyopathy	O
diagnosed	O
in	O
___	O
(outlined	O
below).	O
She	O
had	O
been	O
doing	O
well	O
with	O
fluctuating	O
EF	O
and	O
LV	O
function	O
but	O
without	O
symptoms	O
until	O
___,	O
when	O
she	O
reported	O
mild	O
dyspnea	O
with	O
climbing	O
stairs	O
and	O
no	O
symptoms	O
when	O
walking	O
on	O
flat	O
ground.	O
She	O
also	O
reported	O
dyspnea	O
and	O
occasional	O
palpitations	O
in	O
late	O
___	O
___	O
in	O
the	O
setting	O
of	O
eating	O
more	O
salt	O
while	O
dining	O
out,	O
but	O
attributed	O
this	O
to	O
humidity.	O
.	O
The	O
patient	O
was	O
seen	O
in	O
the	O
ED	O
___	O
for	O
CHF	O
and	O
was	O
diuresed	O
with	O
IV	O
Lasix	O
in	O
the	O
ED	O
per	O
Cardiology	O
consult	O
recs	O
prior	O
to	O
discharge	O
with	O
f/u.	O
She	O
saw	O
her	O
PCP	O
___	O
___	O
for	O
dyspnea	O
at	O
rest,	O
orthopnea,	O
but	O
reported	O
no	O
pedal	O
edema,	O
weight	O
gain,	O
dietary	O
indiscretion,	O
or	O
chest	O
pain.	O
She	O
subsequently	O
saw	O
Dr.	O
___	O
outpatient	O
cardiologist,	O
on	O
___	O
and	O
her	O
HCTZ	O
and	O
Spironolactone	O
were	O
both	O
decreased	O
to	O
half	O
tablets	O
daily.	O
She	O
was	O
found	O
to	O
be	O
in	O
new	O
onset	O
afib	O
and	O
was	O
started	O
on	O
Warfarin.	O
Her	O
blood	O
pressure	O
was	O
also	O
lower	O
than	O
baseline	O
and	O
they	O
had	O
discussed	O
a	O
stepwise	O
transition	O
from	O
Metoprolol	O
succinate	O
to	O
Carvedilol	O
6.25	O
mg	O
daily	O
and	O
the	O
addition	O
of	O
Spironolactone	O
3.125	O
mg	O
daily.	O
She	O
had	O
titrated	O
to	O
Metoprolol	O
50	O
mg	O
daily	O
and	O
Carvedilol	O
3.12	O
mg	O
daily	O
but	O
began	O
experiencing	O
progressive	O
dyspnea	O
with	O
minimal	O
exertion,	O
PND,	O
orthopnea,	O
intermittent	O
palpitations,	O
and	O
pedal	O
edema	O
on	O
___.	O
She	O
denied	O
any	O
chest	O
pain	O
or	O
lightheadedness.	O
.	O
She	O
presented	O
to	O
the	O
ED	O
on	O
___	O
and	O
was	O
admitted	O
for	O
a	O
CHF	O
exacerbation	O
and	O
was	O
diuresed	O
with	O
Lasix.	O
She	O
was	O
in	O
atrial	O
fibrillation	O
and	O
underwent	O
___	O
with	O
DCCV	O
on	O
___	O
and	O
was	O
started	O
on	O
Dofetilide	O
(INR	O
was	O
subtherapeutic	O
as	O
Coumadin	O
was	O
started	O
5	O
days	O
prior	O
to	O
admission).	O
Unfortunately,	O
she	O
subsequently	O
was	O
noted	O
to	O
have	O
QT	O
prolongation	O
and	O
developed	O
torsades	O
de	O
pointes	O
and	O
ventricular	O
fibrillation.	O
She	O
was	O
defibrillated	O
and	O
was	O
transferred	O
to	O
the	O
CCU	O
where	O
electrolytes	O
were	O
aggressively	O
repleted	O
with	O
resolution	O
of	O
QTc.	O
She	O
continued	O
to	O
be	O
in	O
afib	O
and	O
had	O
an	O
bi-V	O
pacer/ICD	O
placed	O
on	O
___	O
with	O
LV	O
lead	O
revision	O
on	O
___,	O
and	O
was	O
loaded	O
on	O
Amiodarone	O
and	O
rate	O
controlled	O
with	O
Metoprolol.	O
She	O
was	O
also	O
started	O
on	O
Aspirin	O
81	O
daily	O
and	O
discharged	O
on	O
Lasix.	O
.	O
The	O
patient	O
presented	O
to	O
the	O
ED	O
on	O
___fter	O
walking	O
into	O
a	O
marble	O
table	O
at	O
2am,	O
and	O
was	O
subsequently	O
cleared	O
and	O
discharged.	O
She	O
was	O
scheduled	O
to	O
undergo	O
outpatient	O
DCCV	O
on	O
___	O
but	O
this	O
was	O
rescheduled	O
in	O
the	O
setting	O
of	O
subtherapeutic	O
INR	O
and	O
unwillingness	O
to	O
undergo	O
TEE.	O
She	O
was	O
planned	O
to	O
continue	O
a	O
three	O
week	O
course	O
of	O
amiodarone	O
200mg	O
TID	O
until	O
___	O
and	O
then	O
start	O
amiodarone	O
200mg	O
daily.	O
She	O
was	O
switched	O
to	O
Dabigatran	O
150	O
mg	O
bid.	O
Following	O
her	O
discharge,	O
she	O
experienced	O
intermittent	O
dyspnea	O
on	O
exertion,	O
nausea,	O
and	O
head	O
pressure	O
with	O
stable	O
1	O
pillow	O
orthopnea	O
and	O
baseline	O
PND.	O
She	O
called	O
her	O
cardiologist	O
on	O
___	O
for	O
these	O
symptoms	O
and	O
her	O
Dagibatran	O
was	O
discontinued	O
and	O
she	O
was	O
switched	O
back	O
to	O
Warfarin.	O
Aspirin	O
had	O
been	O
discontinued,	O
and	O
Lasix	O
was	O
being	O
adjusted	O
based	O
on	O
voiding	O
for	O
unclear	O
reasons	O
(her	O
cardiologist	O
had	O
not	O
been	O
aware	O
of	O
Lasix	O
changes).	O
On	O
___,	O
she	O
was	O
seen	O
by	O
Dr.	O
___	O
noted	O
to	O
be	O
BiV	O
paced	O
only	O
8%,	O
is	O
RV	O
paced	O
at	O
80	O
bpm	O
54%.	O
She	O
complained	O
of	O
dyspnea	O
without	O
chest	O
pain,	O
lightheadedness,	O
or	O
palpitations,	O
and	O
was	O
found	O
to	O
be	O
in	O
atrial	O
fibrillation	O
with	O
RVR	O
with	O
lower	O
than	O
baseline	O
blood	O
pressure.	O
Her	O
Metoprolol	O
was	O
decreased	O
to	O
100	O
mg	O
daily	O
and	O
continued	O
on	O
Amiodarone.	O
Re-starting	O
digoxin	O
was	O
considered.	O
Lisinopril	O
was	O
decreased	O
due	O
to	O
her	O
blood	O
pressure	O
and	O
Spironolactone	O
was	O
held.	O
She	O
called	O
on	O
___	O
with	O
complaints	O
of	O
dyspnea,	O
nausea/vomiting	O
x1,	O
and	O
pedal	O
edema,	O
and	O
was	O
referred	O
to	O
the	O
ED,	O
where	O
she	O
was	O
admitted	O
for	O
CHF	O
exacerbation.	O
She	O
did	O
note	O
eating	O
out	O
more	O
often	O
rather	O
than	O
cooking	O
at	O
home,	O
but	O
did	O
not	O
report	O
medication	O
non-compliance.	O
She	O
also	O
noted	O
home	O
blood	O
pressure	O
readings	O
in	O
the	O
70's-80's	O
systolic.	O
She	O
was	O
diuresed	O
8	O
lbs	O
on	O
a	O
Lasix	O
drip,	O
which	O
was	O
switched	O
to	O
Torsemide	O
prior	O
to	O
discharge.	O
Her	O
Lisinopril	O
was	O
decreased	O
to	O
2.5	O
mg	O
daily	O
prior	O
to	O
discharge	O
and	O
her	O
Spironolactone	O
was	O
restarted	O
at	O
12.5	O
mg	O
daily.	O
Her	O
weight	O
on	O
discharge	O
was	O
143	O
lbs,	O
and	O
her	O
dry	O
weight	O
is	O
~139	O
lbs.	O
EP	O
had	O
recommended	O
cardioversion	O
but	O
the	O
patient	O
refused,	O
as	O
it	O
had	O
been	O
ineffective	O
in	O
the	O
past.	O
She	O
was	O
discharged	O
on	O
Digoxin,	O
Amiodarone	O
200	O
daily,	O
and	O
Metoprolol	O
was	O
increased	O
to	O
200	O
mg	O
daily.	O
Following	O
discharge,	O
she	O
most	O
recently	O
saw	O
Dr.	O
___	O
___	O
in	O
clinic	O
on	O
___	O
and	O
was	O
rescheduled	O
for	O
TEE	O
and	O
cardioversion.	O
Digoxin	O
was	O
increased	O
to	O
0.125	O
mg	O
daily	O
at	O
that	O
visit	O
for	O
better	O
rate	O
control.	O
Unfortunately,	O
she	O
developed	O
her	O
symptoms	O
outlined	O
above	O
and	O
returned	O
to	O
the	O
ED	O
today	O
for	O
her	O
AICD	O
firing.	O
.	O
In	O
the	O
ED,	O
initial	O
vitals	O
were	O
97.5	O
73	O
136/96	O
20	O
96%	O
RA	O
The	O
patient	O
had	O
no	O
further	O
epsidoes	O
of	O
AICD	O
firing	O
and	O
denied	O
chest	O
pain,	O
palpitations,	O
dyspnea	O
in	O
the	O
ED.	O
EKG	O
showed	O
paced	O
rhythm	O
without	O
evidence	O
of	O
ischemia,	O
and	O
telemetry	O
reportedly	O
showed	O
occasional	O
unifocal	O
PVCs.	O
EP	O
was	O
consulted	O
and	O
interrogated	O
her	O
pacemaker,	O
which	O
showed	O
multiple	O
episodes	O
of	O
fast	O
VT	O
and	O
polymorphic	O
VT	O
in	O
the	O
past	O
two	O
days	O
which	O
were	O
non-sustained,	O
terminated	O
with	O
ATP,	O
or	O
defibrillated.	O
The	O
patient	O
given	O
Digoxin	O
0.125	O
mg,	O
Amiodarone	O
200	O
mg,	O
Lisinopril	O
5	O
mg,	O
Metoprolol	O
XL	O
100	O
mg,	O
Torsemide	O
20	O
mg,	O
Acetaminophen	O
650	O
mg	O
for	O
a	O
headache.	O
She	O
was	O
admitted	O
to	O
cardiology	O
for	O
further	O
evaluation.	O
Vitals	O
on	O
transfer	O
were	O
97.4	O
60	O
16	O
108/55	O
98%	O
RA	O
.	O
On	O
arrival	O
to	O
the	O
floor,	O
patient	O
denies	O
any	O
symptoms	O
including	O
chest	O
pain,	O
dyspnea,	O
lightheadedness,	O
nausea,	O
palpitations.	O
She	O
had	O
no	O
other	O
complaints.	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS:	O
Hypertension,	O
Dyslipidemia	O
.	O
2.	O
CARDIAC	O
HISTORY:	O
-PERCUTANEOUS	O
CORONARY	O
INTERVENTIONS:	O
-PACING/ICD:	O
VF	O
arrest	O
s/p	O
___	O
Unify	O
Biventricular	O
ICD	O
___.	O
.	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
Nonischemic	O
cardiomyopathy	O
diagnosed	O
in	O
___,	O
LVEF	O
20%	O
-	O
Biventricular	O
dilation	O
with	O
severe	O
global	O
LV	O
hypokinesis	O
-	O
Mitral	O
valve	O
prolapse	O
with	O
4+	O
MR	O
-	O
Mild-to-moderate	O
tricuspid	O
regurgitation	O
-	O
Pulmonary	O
hypertension	O
-	O
Atrial	O
fibrillation	O
with	O
RVR,	O
s/p	O
TEE	O
and	O
cardioversion	O
x2.	O
-	O
Torsades	O
while	O
on	O
dofetilide	O
-	O
Intermittent	O
LBBB	O
-	O
Past	O
thallium	O
stress	O
test	O
___	O
with	O
moderate	O
fixed	O
perfusion	O
defects	O
of	O
the	O
septum,	O
mild	O
fixed	O
perfusion	O
defect	O
of	O
the	O
anterior	O
wall	O
and	O
apex.	O
-	O
Complex	O
aortic	O
atheroma	O
seen	O
on	O
recent	O
___	O
.	O
-	O
Rheumatoid	O
arthritis	O
-	O
Orthostatic	O
hypotension	O
-	O
Diverticulosis	O
-	O
s/p	O
laparoscopic	O
cholecystectomy	O
and	O
cholangiogram	O
___.	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
with	O
hypertension,	O
died	O
from	O
a	O
stroke	O
at	O
age	O
___.	O
Mother	O
with	O
heart	O
disease	O
in	O
___,	O
lived	O
to	O
be	O
___	O
and	O
three	O
sisters	O
with	O
hypertension.	O
Paternal	O
aunt	O
had	O
an	O
MI	O
at	O
age	O
___.	O
Sister	O
has	O
breast	O
cancer.	O
Physical	O
Exam:	O
VS:	O
97.7	O
138/68	O
60	O
18	O
97%RA	O
Wt	O
63.9	O
kg	O
(s)	O
GENERAL:	O
Alert,	O
oriented,	B-Delirium
interactive,	O
NAD.	O
Mood,	O
affect	O
appropriate.	O
HEENT:	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthalesma.	O
NECK:	O
Supple	O
with	O
JVP	O
<9cm.	O
CARDIAC:	O
PMI	O
displaced	O
laterally,	O
located	O
in	O
___	O
intercostal	O
space.	O
RRR	O
with	O
frequent	O
ectopy,	O
normal	O
S1,	O
S2.	O
No	O
m/r/g	O
appreciated.	O
Slight	O
RV	O
heave.	O
No	O
S3	O
or	O
S4.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
CTAB,	O
trace	O
crackles	O
at	O
RLB,	O
no	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
HSM.	O
+BS.	O
EXTREMITIES:	O
No	O
c/c,	O
trace	O
pedal	O
edema.	O
SKIN:	O
No	O
stasis	O
dermatitis,	O
ulcers,	B-Pressure_injury
scars,	O
or	O
xanthomas.	O
PULSES:	O
Right:	O
Carotid	O
2+	O
DP	O
2+	O
___	O
2+	O
Left:	O
Carotid	O
2+	O
DP	O
2+	O
___	O
2+	O
Pertinent	O
Results:	O
138	O
96	O
20	O
------------	O
120	O
5.2	O
29	O
0.9	O
Repeat	O
K	O
3.6	O
Ca:	O
9.8	O
Mg:	O
1.7	O
P:	O
3.5	O
14.0	O
6.4	O
------	O
239	O
42.6	O
N:71.0	O
L:18.5	O
M:7.4	O
E:2.7	O
Bas:0.5	O
___:	O
48.9	O
PTT:	O
42.8	O
INR:	O
4.8	O
UA	O
(___):	O
negative.	O
CXR	O
(___):	O
No	O
acute	O
cardiopulmonary	O
process	O
EKG	O
(___):	O
Native	O
atrial	O
beats	O
with	O
ventricular	O
pacing	O
@	O
65	O
bpm,	O
LBBB	O
pattern,	O
no	O
evidence	O
of	O
acute	O
ischemia	O
by	O
sgarbossa	O
criteria,	O
QTc	O
466	O
ms.	O
___	O
(___):	O
The	O
left	O
atrium	O
is	O
mildly	O
dilated.	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
Left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal.	O
The	O
left	O
ventricular	O
cavity	O
is	O
moderately	O
dilated.	O
There	O
is	O
mild	O
to	O
moderate	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
basal	O
to	O
mid	O
infero-lateral	O
akinesis	O
and	O
distal	O
septal/apical	O
hypokinesis.	O
No	O
masses	O
or	O
thrombi	O
are	O
seen	O
in	O
the	O
left	O
ventricle.	O
There	O
is	O
no	O
ventricular	O
septal	O
defect.	O
The	O
right	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
with	O
normal	O
free	O
wall	O
contractility.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Moderate	O
(2+)	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
The	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
determined.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
the	O
LVEF	O
and	O
RVEF	O
have	O
improved.	O
The	O
degree	O
of	O
MR	O
has	O
decreased.	O
EF	O
40%.	O
Brief	O
Hospital	O
Course:	O
___	O
year	O
old	O
female	O
nonischemic	O
cardiomyopathy	O
(EF	O
20%),	O
HTN,	O
mitral	O
valve	O
prolapse	O
with	O
severe	O
MR,	O
atrial	O
fibrillation,	O
VF	O
arrest	O
s/p	O
BiV	O
ICD	O
placement	O
___,	O
now	O
presenting	O
with	O
AICD	O
firing	O
x3	O
for	O
polymorphic	O
VT	O
and	O
fast	O
___.	O
.	O
#	O
Ventricular	O
Tachycardia:	O
Patient	O
has	O
a	O
recent	O
history	O
of	O
VF	O
arrest	O
status	O
___	O
Unify	O
Biventricular	O
ICD	O
placement	O
___.	O
The	O
patient	O
currently	O
presents	O
with	O
2	O
episodes	O
of	O
her	O
AICD	O
firing,	O
found	O
to	O
be	O
___	O
multiple	O
episodes	O
of	O
fast	O
VT	O
and	O
polymorphic	O
VT	O
on	O
interrogation.	O
Of	O
note,	O
the	O
patient	O
has	O
had	O
intermittent	O
LBBB	O
and	O
had	O
stress	O
tests	O
subsequently	O
which	O
did	O
not	O
show	O
LBBB	O
associated	O
with	O
exertion	O
or	O
ischemia.	O
(See	O
HPI	O
for	O
full	O
prior	O
history	O
of	O
prior	O
hospitalizations	O
and	O
outpatient	O
care.)	O
The	O
evening	O
of	O
admission,	O
the	O
patient	O
had	O
a	O
syncopal	O
event	O
secondary	O
to	O
polymorphic	O
___	O
and	O
her	O
AICD	O
fired	O
appropriately	O
to	O
terminate	O
the	O
arrhythmia.	O
Workup	O
for	O
the	O
___	O
was	O
unrevealing	O
for	O
ischemia	O
with	O
essentially	O
negative	O
cardiac	O
enzymes	O
(negative	O
MB,	O
stable	O
Trop).	O
___	O
showed	O
improved	O
cardiac	O
function	O
with	O
EF	O
40%	O
and	O
improved	O
MR.	O
___	O
new	O
onset	O
___	O
were	O
believed	O
to	O
be	O
secondary	O
to	O
Digoxin	O
use	O
(recently	O
restarted	O
and	O
then	O
doubled	O
as	O
outpatient,	O
level	O
of	O
1.4	O
on	O
admission).	O
A	O
less	O
likely	O
possibility	O
is	O
her	O
underlying	O
non-ischemic	O
cardiomyopathy,	O
although	O
___	O
showed	O
improvement.	O
Digoxin	O
was	O
discontinued	O
and	O
the	O
patient's	O
amiodarone	O
was	O
doubled	O
to	O
200	O
mg	O
bid.	O
Her	O
pacemaker	O
settings	O
were	O
also	O
increased	O
to	O
80	O
bpm	O
from	O
60	O
bpm	O
prior	O
to	O
admission.and	O
electrolytes	O
were	O
aggressively	O
repleted.	O
TSH	O
7,	O
free	O
T4	O
normal.	O
She	O
had	O
no	O
other	O
episodes	O
of	O
VT	O
or	O
AICD	O
firing	O
and	O
was	O
discharged	O
with	O
close	O
follow-up.	O
#.	O
Atrial	O
Fibrillation:	O
The	O
patient	O
developed	O
new	O
onset	O
atrial	O
fibrillation	O
on	O
___,	O
s/p	O
failed	O
cardioversion	O
currently	O
on	O
Amiodarone	O
with	O
another	O
cardioversion	O
scheduled	O
as	O
an	O
outpatient	O
(had	O
torsades	O
when	O
she	O
was	O
initially	O
started	O
on	O
Dofetilide).	O
However,	O
the	O
patient	O
was	O
in	O
sinus	O
rhythm	O
on	O
presentation,	O
likely	O
___	O
her	O
AICD	O
firing,	O
and	O
maintained	O
a	O
normal	O
rhythm	O
throughout	O
her	O
hospital	O
stay.	O
Her	O
INR	O
was	O
supratherapeutic	O
on	O
admission	O
and	O
Coumadin	O
was	O
held	O
until	O
her	O
INR	O
decreased	O
to	O
therapeutic	O
levels.	O
She	O
was	O
discharged	O
on	O
a	O
lower	O
dose	O
of	O
Coumadin	O
with	O
outpatient	O
followup	O
of	O
her	O
INR.	O
.	O
#	O
Non-ischemic	O
Dilated	O
Cardiomyopathy:	O
Patient	O
has	O
a	O
history	O
of	O
nonischemic	O
cardiomyopathy	O
diagnosed	O
in	O
___,	O
with	O
LVEF	O
20%	O
with	O
biventricular	O
dilation,	O
severe	O
global	O
LV	O
hypokinesis,	O
mitral	O
valve	O
prolapse	O
with	O
4+	O
MR,	O
and	O
mild-to-moderate	O
tricuspid	O
regurgitation	O
at	O
that	O
time.	O
Her	O
EF	O
subsequently	O
improved	O
to	O
up	O
to	O
50%	O
as	O
seen	O
on	O
cardiac	O
MRI	O
and	O
subsequent	O
___,	O
and	O
fluctuated	O
(as	O
detailed	O
below)	O
until	O
___	O
___	O
which	O
showed	O
EF	O
40-45%,	O
TR	O
gradient	O
less	O
than	O
20.	O
Subsequent	O
___	O
___	O
showed	O
EF	O
30%,	O
TR	O
gradient	O
30,	O
inferior	O
lateral	O
hypo	O
to	O
akinesis,	O
and	O
more	O
prominent	O
regional	O
dysfunction.	O
Most	O
recent	O
___	O
in	O
___	O
showed	O
___,	O
moderate	O
LV	O
dilation,	O
4+	O
MR,	O
significant	O
pulmonic	O
regurgitation,	O
___	O
TR,	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	O
(LVEF	O
=	O
20%,	O
likely	O
overestimated	O
given	O
degree	O
of	O
MR).	O
Her	O
outpatient	O
cardiologist	O
was	O
considering	O
repeat	O
stress	O
test	O
and	O
cardiac	O
MR	O
___	O
this	O
is	O
now	O
not	O
possible	O
due	O
to	O
her	O
ICD/pacemaker)	O
for	O
further	O
evaluation	O
given	O
decline	O
of	O
her	O
cardiac	O
function.	O
However,	O
a	O
___	O
obtained	O
in-house	O
on	O
this	O
admission	O
showed	O
improved	O
LV	O
function	O
with	O
improved	O
EF	O
of	O
40%	O
and	O
improved	O
MR.	O
___	O
patient	O
was	O
continued	O
on	O
her	O
home	O
regimen	O
of	O
Torsemide,	O
Metoprolol,	O
Lisinopril,	O
Spironolactone	O
was	O
was	O
euvolemic	O
without	O
evidence	O
of	O
heart	O
failure.	O
She	O
was	O
discharged	O
on	O
an	O
increased	O
dose	O
of	O
Spironolactone	O
and	O
lower	O
dose	O
of	O
Torsemide,	O
with	O
outpatient	O
follow-up	O
with	O
Dr.	O
___.	O
.	O
#	O
CORONARIES:	O
The	O
patient	O
had	O
chest	O
pain	O
and	O
dyspnea	O
in	O
___	O
and	O
underwent	O
a	O
thallium	O
stress	O
test	O
which	O
was	O
terminated	O
for	O
fatigue	O
and	O
during	O
which	O
she	O
had	O
no	O
symptoms.	O
However,	O
a	O
moderate	O
fixed	O
perfusion	O
defect	O
of	O
the	O
septum	O
and	O
mild	O
fixed	O
perfusion	O
defect	O
of	O
the	O
anterior	O
wall	O
and	O
apex	O
was	O
seen	O
at	O
that	O
time,	O
as	O
well	O
as	O
moderate	O
LV	O
dilation	O
and	O
EF	O
30%.	O
___	O
___	O
showed	O
mild	O
left	O
atrial	O
enlargement,	O
EF	O
___,	O
moderate	O
MR.	O
___	O
underwent	O
cardiac	O
MR	O
in	O
___	O
which	O
showed	O
normal	O
coronary	O
artery	O
origins	O
with	O
no	O
evidence	O
of	O
anomalous	O
coronary	O
arteries	O
and	O
normal	O
signal	O
of	O
all	O
visualized	O
segments	O
consistent	O
with	O
nonischemic	O
cardiomyopathy.	O
She	O
was	O
medically	O
managed.	O
Repeat	O
___	O
___	O
showed	O
slight	O
improvement	O
of	O
LV	O
dilation	O
and	O
EF	O
(<25%).	O
___,	O
___	O
showed	O
EF	O
35-40,	O
TR	O
gradient	O
21.	O
On	O
___,	O
___	O
showed	O
EF	O
50%,	O
TR	O
gradient	O
33-37,	O
moderate	O
MR.	O
___	O
had	O
a	O
repeat	O
stress	O
test	O
in	O
___	O
on	O
a	O
modified	O
___	O
protocol	O
for	O
7.5	O
minutes	O
with	O
EF	O
50%,	O
no	O
new	O
perfusion	O
defects,	O
no	O
LBBB.	O
___	O
in	O
___	O
showed	O
EF	O
40%,	O
TR	O
gradient	O
___,	O
mild-to-moderate	O
MR	O
and	O
she	O
underwent	O
a	O
stress	O
test	O
which	O
showed	O
LBBB	O
at	O
rest,	O
EF	O
___,	O
no	O
evidence	O
of	O
ischemia	O
or	O
symptoms.	O
On	O
___,	O
___	O
showed	O
EF	O
40-45%,	O
TR	O
gradient	O
<20,	O
mild	O
global	O
LV	O
hypokinesis,	O
normal	O
regional	O
function,	O
mild-to-moderate	O
MR	O
___	O
to	O
findings	O
in	O
___.	O
Repeat	O
stress	O
echo	O
in	O
___	O
showed	O
worsened	O
EF	O
___,	O
LBBB	O
at	O
rest,	O
TR	O
gradient	O
30,	O
normal	O
IVC,	O
normal	O
RA	O
pressure,	O
inferior	O
lateral	O
hypo	O
to	O
akinesis	O
(more	O
prominent	O
regional	O
dysfunction	O
compared	O
to	O
___.	O
However,	O
repeat	O
___	O
on	O
this	O
admission	O
showed	O
improvement	O
of	O
LV	O
function	O
with	O
EF	O
40%	O
and	O
improved	O
MR.	O
___	O
patient	O
was	O
asymptomatic	O
for	O
anginal	O
symptoms	O
with	O
negative	O
CE's	O
and	O
no	O
EKG	O
changes,	O
and	O
she	O
was	O
continued	O
on	O
her	O
home	O
Aspirin	O
81	O
mg	O
daily	O
for	O
primary	O
prevention.	O
.	O
#.	O
Hypertension:	O
Patient	O
has	O
history	O
of	O
difficult	O
to	O
control	O
hypertension	O
on	O
high	O
doses	O
of	O
anti-hypertensives	O
and	O
also	O
complicated	O
by	O
a	O
history	O
of	O
orthostatic	O
hypotension.	O
BP	O
was	O
fairly	O
well	O
controlled	O
in-house,	O
and	O
she	O
was	O
continued	O
on	O
her	O
home	O
regimen	O
of	O
Metoprolol,	O
Lisinopril,	O
and	O
Spironolactone.	O
.	O
#.	O
Dyslipidemia:	O
Patient	O
has	O
recent	O
elevated	O
LDL	O
in	O
the	O
140's	O
and	O
mylagia	O
with	O
statins.	O
Given	O
a	O
prior	O
cardiac	O
MRI	O
had	O
shown	O
no	O
CAD	O
and	O
her	O
stress	O
tests	O
have	O
been	O
negative	O
for	O
ischemia,	O
she	O
has	O
been	O
managed	O
with	O
weight	B-Weight_loss
loss	B-Weight_loss
and	O
lifestyle	O
modifications.	O
Fish	O
oil,	O
omega-3-fatty	O
acids	O
had	O
been	O
discussed	O
and	O
she	O
has	O
fish	O
oil	O
pills	O
at	O
home	O
but	O
had	O
not	O
been	O
taking	O
them	O
consistently.	O
She	O
was	O
started	O
in-house	O
on	O
fish	O
oil	O
1	O
gm	O
bid	O
for	O
her	O
dyslipidemia,	O
and	O
counseled	O
on	O
continuing	O
this	O
as	O
an	O
outpatient.	O
.	O
#.	O
Pulmonary	O
hypertension:	O
Stable,	O
no	O
dyspnea.	O
Potential	O
indication	O
for	O
outpatient	O
sleep	O
study	O
given	O
progressive	O
pulmonary	O
hypertension	O
and	O
history	O
of	O
snoring	O
when	O
sleeping.	O
.	O
.	O
CODE:	O
Full	O
(confirmed	O
with	O
pt)	O
EMERGENCY	O
CONTACT:	O
___	O
(cell)	O
___,	O
(home)	O
___.	O
TRANSITIONS	O
OF	O
CARE:	O
-	O
Follow-up	O
on	O
INR	O
and	O
adjust	O
Coumadin	O
dose	O
given	O
increased	O
Amiodarone	O
dose	O
and	O
supratherapeutic	O
INR	O
on	O
admission.	O
-	O
Follow-up	O
on	O
electrolytes	O
given	O
change	O
of	O
diuretic	O
regimen.	O
-	O
Amiodarone	O
dose	O
was	O
increased	O
to	O
200	O
mg	O
bid	O
from	O
200	O
mg	O
daily.	O
Consider	O
decreasing	O
back	O
to	O
original	O
dose	O
when	O
Digoxin	O
has	O
washed	O
out.	O
-	O
Follow-up	O
with	O
Cardiology/EP	O
whether	O
pacer	O
settings	O
should	O
be	O
decreased	O
from	O
80	O
bpm	O
back	O
to	O
60	O
bpm	O
after	O
Digoxin	O
wash-out.	O
-	O
No	O
digoxin	O
in	O
the	O
future.	O
Medications	O
on	O
Admission:	O
1.	O
torsemide	O
20	O
mg	O
Tablet	O
Sig:	O
Four	O
(4)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
lisinopril	O
5	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
amiodarone	O
200	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
4.	O
digoxin	O
125	O
mcg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
spironolactone	O
25	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
zolpidem	O
5	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
HS	O
prn	O
Sleep.	O
7.	O
metoprolol	O
succinate	O
100	O
mg	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
Sig:	O
Two	O
(2)	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
8.	O
potassium	O
chloride	O
20	O
mEq	O
Tablet,	O
ER	O
Particles/Crystals	O
Sig:	O
One	O
(1)	O
Tablet,	O
ER	O
Particles/Crystals	O
PO	O
once	O
a	O
day.	O
9.	O
warfarin	O
2	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
Once	O
Daily	O
at	O
4	O
___.	O
Discharge	O
Medications:	O
1.	O
senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
constipation.	B-Constipation
2.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
3.	O
torsemide	O
20	O
mg	O
Tablet	O
Sig:	O
Three	O
(3)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
lisinopril	O
5	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
5.	O
spironolactone	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet(s)*	O
Refills:*0*	O
6.	O
zolpidem	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime)	O
as	O
needed	O
for	O
insomnia:	O
You	O
should	O
not	O
drive	O
or	O
do	O
anything	O
that	O
requires	O
alertness	O
while	O
taking	O
this	O
medication.	O
7.	O
metoprolol	O
succinate	O
100	O
mg	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
Sig:	O
Two	O
(2)	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
PO	O
once	O
a	O
day.	O
8.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
9.	O
omega-3	O
fatty	O
acids	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
10.	O
amiodarone	O
200	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
Disp:*60	O
Tablet(s)*	O
Refills:*0*	O
11.	O
warfarin	O
2	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Once	O
Daily	O
at	O
4	O
___.	O
12.	O
Outpatient	O
Lab	O
Work	O
Please	O
have	O
___	O
and	O
BMP	O
with	O
Mg	O
checked	O
on	O
Moday,	O
___	O
Please	O
fax	O
results	O
to	O
___.	O
___	O
at	O
___:	O
___	O
and	O
Phone:	O
___,	O
and	O
to	O
___.	O
___	O
___	O
at	O
___:	O
___	O
Phone:	O
___	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Primary:	O
Ventricular	O
tachycardia-ICD	O
firing	O
for	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___.	O
You	O
were	O
admitted	O
for	O
your	O
AICD	O
firing	O
with	O
an	O
episode	O
while	O
you	O
were	O
here	O
of	O
ventricular	O
tachycardia	O
and	O
syncope.	O
Your	O
pacer	O
setting	O
was	O
increased	O
to	O
80	O
BPM	O
with	O
decrease	O
in	O
ectopy,	O
amiodarone	O
increased	O
to	O
200	O
mg	O
twice	O
a	O
day,	O
and	O
digoxin	O
discontinued.	O
Since	O
then,	O
you	O
have	O
have	O
no	O
further	O
episodes	O
of	O
ventricular	O
tachycardia.	O
We	O
have	O
made	O
the	O
following	O
changes	O
to	O
your	O
medications:	O
-	O
INCREASED	O
AMIODERONE	O
from	O
200mg	O
once	O
daily	O
to	O
twice	O
daily	O
-	O
DECREASE	O
TORSIMIDE	O
to	O
60mg	O
once	O
daily	O
-	O
INCREASE	O
SPIROLACTONE	O
to	O
25mg	O
-	O
STOP	O
Digoxin	O
-	O
STOP	O
POTASSIUM	O
until	O
Dr.	O
___	O
you	O
to	O
continue	O
-	O
DECREASED	O
COUMADIN	O
from	O
3mg	O
to	O
2mg	O
given	O
that	O
your	O
dose	O
of	O
Amioderone	O
was	O
increased.	O
Your	O
INR	O
(coumadin	O
level)	O
is	O
3.1	O
today.	O
You	O
should	O
continue	O
all	O
your	O
other	O
medications	O
in	O
addition	O
to	O
potassium.	O
You	O
will	O
need	O
to	O
have	O
blood	O
work	O
checked	O
on	O
___	O
for	O
both	O
your	O
coumadin	O
levels	O
and	O
your	O
electrolytes.	O
Weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
Followup	O
Instructions:	O
___	O

